FDA 510(k)

Largan 55 UV Color (Ocufilcon D) Daily Wear Soft (hydrophilic) Contact Lens

Numéro K : K182523 · 2018-11-01

Date de décision2018-11-01

Code produitLPL

Comité consultatifOP

DécisionSubstantially Equivalent

Résumé du dispositif

Largan 55 UV Color (Ocufilcon D) Daily Wear Soft (hydrophilic) Contact Lens is the device name listed in this FDA 510(k) record. The listed applicant is Largan Medical Co., Ltd.. It received FDA 510(k) clearance on 2018-11-01 under 510(k) number K182523. The device is classified under product code LPL. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Questions fréquentes

What is the Largan 55 UV Color (Ocufilcon D) Daily Wear Soft (hydrophilic) Contact Lens?

Largan 55 UV Color (Ocufilcon D) Daily Wear Soft (hydrophilic) Contact Lens is a medical device that received FDA 510(k) clearance on 2018-11-01. The listed applicant is Largan Medical Co., Ltd.. The 510(k) number is K182523.

When did Largan 55 UV Color (Ocufilcon D) Daily Wear Soft (hydrophilic) Contact Lens receive FDA 510(k) clearance?

Largan 55 UV Color (Ocufilcon D) Daily Wear Soft (hydrophilic) Contact Lens received FDA 510(k) clearance on 2018-11-01, under 510(k) number K182523.

Who is the listed applicant for Largan 55 UV Color (Ocufilcon D) Daily Wear Soft (hydrophilic) Contact Lens?

The FDA 510(k) record lists Largan Medical Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Largan 55 UV Color (Ocufilcon D) Daily Wear Soft (hydrophilic) Contact Lens?

The FDA product code for Largan 55 UV Color (Ocufilcon D) Daily Wear Soft (hydrophilic) Contact Lens is LPL.

Essais cliniques associés

Les enregistrements connexes sont mis en correspondance automatiquement à l'aide des noms, codes produits ou autres métadonnées. Une mise en correspondance n'établit pas de relation clinique, scientifique, corporative ou réglementaire vérifiée ; veuillez consulter les sources officielles liées.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Autres dossiers indiquant Largan Medical Co., Ltd. en tant que demandeur

Voir tous les 8 dispositifs →

Dispositifs connexes (Code : LPL)

Source officielle

Voir dans la base de données FDA →

Données issues de l'API ouverte de la FDA. Pour les informations les plus récentes et faisant autorité, veuillez toujours vous référer au registre officiel.